EarningsQ4 2023 Earnings Report

Innate Pharma (IDDA) Q4 2023 Earnings Report

1 Followers

DE:IDDA Q4 2023 EPS Results

Actual EPS-€0.11

Consensus EPS-€0.38

Beat/MissBeat by +€0.27

One Year Ago EPS-€0.77

Actual Revenue€15.75M

Expected Revenue€15.96M

Beat/MissMissed by -€211.16K

YoY Revenue Growth+112.69%

QuarterQ4 2023

Date03/21/2024

TimeBefore Open

Conference CallThursday, March 21, 2024

DE:IDDA Upcoming Earnings

Innate Pharma's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

DE:IDDA Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 25, 2027	2026 (Q4)	-0.25 / -	-0.315	―
Sep 17, 2026	2026 (Q2)	-0.16 / -0.21	-0.26	18.58% (+0.05)
Mar 26, 2026	2025 (Q4)	-0.12 / -0.31	-0.304	-3.47% (-0.01)
Sep 17, 2025	2025 (Q2)	-0.29 / -0.26	-0.301	13.45% (+0.04)
Mar 27, 2025	2024 (Q4)	-0.23 / -0.30	-0.114	-166.15% (-0.19)
Sep 12, 2024	2024 (Q2)	-0.26 / -0.30	0.018	-1728.57% (-0.32)
Mar 21, 2024	2023 (Q4)	-0.38 / -0.11	-0.774	85.23% (+0.66)
Sep 14, 2023	2023 (Q2)	0.08 / 0.02	0.07	-73.75% (-0.05)
Mar 23, 2023	2022 (Q4)	-0.36 / -0.77	-0.332	-132.80% (-0.44)
Sep 15, 2022	2022 (Q2)	0.33 / 0.07	-0.312	122.54% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed